The results of a web-based randomized controlled intervention trial to improve antiretroviral therapy (ART) adherence among Youth with HIV (YouTHrive, ATN 135) during the COVID-19 pandemic
Web-based randomized controlled trial shows no improvement in ART adherence among youth with HIV, suggesting further study design considerations are necessary.
Key Points
ART adherence did not improve among youth with HIV in the study.
Viral load metrics did not show significant changes, indicating possible intervention challenges.
Randomized controlled trial evaluated the YouTHrive intervention amidst pandemic-related disruptions.
Future research should address methods to reduce pandemic impacts on similar studies.